Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 25;16(11):2299–2309. doi: 10.4103/1673-5374.309843

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Neural Regeneration Research

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

PMC Copyright notice

Effect of the new benzimidazole derivatives on synaptosomal viability.

Synaptosomal viability was assessed after treatment with various concentrations of the new benzimidazole arylhydrazones (50, 100 and 200 μM): compound 3 (A), compound 4 (B), compound 5 (C), compound 6 (D), compound 7 (E), compound 8 (F) and after treatment with the reference compounds melatonin (G) and rasagiline (H) at the same concentrations. Data are presented as means from five independent experiments ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, vs. control group (one-way analysis of variance with Dunnet’s post hoc test).